Drug Safety Matters
Skupno trajanje:
21 h 47 min
#36 Pregnancy-related pharmacovigilance – Levente Pápai, Lovisa Sandberg & Sara Vidlin
Drug Safety Matters
36:44
#35 Veterinary pharmacovigilance part 2 – James Mount
Drug Safety Matters
41:42
#34 Veterinary pharmacovigilance, Part I – James Mount
Drug Safety Matters
47:21
#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias
Drug Safety Matters
38:43
#32 Pharmacovigilance in older adults – Giovanni Furlan
Drug Safety Matters
47:51
#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori
Drug Safety Matters
42:45
Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects
Drug Safety Matters
25:02
Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance
Drug Safety Matters
30:18
#30 Preventing and reporting medication errors – Rabat CC & UMC
Drug Safety Matters
33:58
#29 When medicines change our behaviour – Michele Fusaroli
Drug Safety Matters
30:30
#28 Catching black swans – François Montastruc
Drug Safety Matters
27:21
#27 When drugs damage the liver – Rita Baião
Drug Safety Matters
28:30
#26 What's trending in pharmacovigilance? – Angela Caro
Drug Safety Matters
28:06
#25 A week in the name of medicines safety – part 2
Drug Safety Matters
33:13
#24 A week in the name of medicines safety – part 1
Drug Safety Matters
27:09
Uppsala Reports Long Reads – The colour of signals
Drug Safety Matters
33:59
Uppsala Reports Long Reads – Empowering patients as partners
Drug Safety Matters
42:43
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Drug Safety Matters
31:06
#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters
32:54
#21 Unlocking the power of real-world data – Patrick Ryan
Drug Safety Matters
33:42
#20 The evidence for signals – Daniele Sartori
Drug Safety Matters
45:41
Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era
Drug Safety Matters
21:19
#19 Lessons in pandemic pharmacovigilance – Elena Rocca
Drug Safety Matters
33:11
#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund
Drug Safety Matters
23:06
#17 Why we need vaccine surveillance systems – Madhava Balakrishnan
Drug Safety Matters
27:30
#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras
Drug Safety Matters
33:42
#15 Safety of HIV medications – Henry Zakumumpa
Drug Safety Matters
33:19
#14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry
Drug Safety Matters
37:20
#13 How to talk about risks – Alexandra Freeman
Drug Safety Matters
38:16
Uppsala Reports Long Reads – Safety issues faced by refugee communities
Drug Safety Matters
25:08
#12 Improving signal detection with vigiGroup – Jim Barrett & Joe Mitchell
Drug Safety Matters
23:21
#11 Talking about vaccine safety – Anthony Cox & Daniel Salmon
Drug Safety Matters
28:52
Uppsala Reports Long Reads – The KIDs List
Drug Safety Matters
31:08
Uppsala Reports Long Reads – Convincing the vaccine hesitant
Drug Safety Matters
34:52
#10 Tailoring drug therapy to your genes – Qun-Ying Yue
Drug Safety Matters
29:37
#9 Keeping vaccines safe – Helena Sköld & Annette Rudolph
Drug Safety Matters
26:44
Uppsala Reports Long Reads – Substandard and falsified COVID-19 vaccines in the Americas
Drug Safety Matters
21:06
#8 How do we change behaviour around antimicrobial resistance?
Drug Safety Matters
47:39
Uppsala Reports Long Reads – Into the infodemic
Drug Safety Matters
27:17
#7 The challenge of rare diseases – Christina Ström Möller
Drug Safety Matters
24:15
